Pharmaceutical Intermediates Market Size, Share, Growth Report 2030

Pharmaceutical Intermediates Market

Pharmaceutical Intermediates Market - By Application (Antibiotics, Antipyretic Analgesics, and Vitamins), By Product Type (GMP and Non-GMP), By Distribution Channel (Direct Sales and Distributor), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2028

Category: Pharmaceutical Report Format : PDF Pages: 187 Report Code: ZMR-3440 Published Date: Nov-2021 Status : Published

The global Pharmaceutical Intermediates Market accrued earnings worth approximately 28,117 (USD Million) in 2020 and is predicted to gain revenue of about 39,779 (USD Million) by 2028, is set to record a CAGR of nearly 4.1% over the period from 2021 to 2028.

Pharmaceutical Intermediates Market

The global Pharmaceutical Intermediates Marketaccrued earnings worth approximately 28,117 (USD Million) in 2020and is predicted to gain revenue of about 39,779 (USD Million) by2028, is set to record a CAGR of nearly 4.1% over the period from2021 to 2028. The report offers assessment and analysis of thePharmaceutical Intermediates Market on a globaland regional level. The study offers a comprehensive assessment ofthe market competition, constraints, revenue estimates,opportunities, evolving trends, and industry-validated data. Thereport provides historical data from 2018 to 2020 along with aforecast from 2021 to 2028 based on revenue (USD Million).

Pharmaceutical Intermediates Market:Overview

Pharmaceutical Intermediates are utilized as raw componentsduring bulk drug production. Moreover, they are chemical compoundsthat form building blocks of active pharmaceutical ingredient(API). These products are produced as by-products while producingAPI. Nonetheless, bio-pharma and pharma firms are focusing onimproving their product reach in various countries across globe.These firms are trying to increase production capacities indifferent parts of globe.

Global Pharmaceutical Intermediates MarketRequest Free Sample

Pharmaceutical Intermediates Market: GrowthDrivers

Rise in occurrence of chronic disorders such as diabetes, heartailments, and kidney-related problems will drive market trends. Asper WHO, persons above sixty years of age is projected to surpass 2billion by 2050. Reportedly, WHO has also claimed diabetes to bemajor cause of heart attack, kidney failure, and stoke. In additionto this, prominently surging geriatric population will embellishgrowth of Pharmaceutical Intermediates Market over anticipatedtimeline. Apparently, use of new technologies including highthroughput, combinatorial chemistry, and bio-informatics will propup expansion of Pharmaceutical Intermediates industry over forecasttimespan. Growing reach of various pharma players in emergingeconomies will pave way for expansion of PharmaceuticalIntermediates market over assessment timeline.

Report Scope:

Furthermore, wide use of Pharmaceutical Intermediates Market indomain of clinical research will prompt business expansion inupcoming years. In addition to this, outbreak of COVID-19 pandemichas encouraged players in biotech and pharmaceutical sectors tofocus on drug production activities, thereby enlarging scope ofPharmaceutical Intermediates industry over assessment period.

Regional Landscape

North America To Dominate Overall Market Growth By2028

Expansion of Pharmaceutical Intermediates Market in NorthAmerica over assessment period is due to surge in research &development activities in countries such as Canada and the U.S.Apart from this, surge in occurrence of myriad chronic conditionswill further contribute towards regional market proceeds overupcoming years. For the record, heart disorder causes nearly 8 lacdeaths in the U.S.

Competitive Landscape

Key participants leveraging growth of PharmaceuticalIntermediates Market and profiled in study include Codexis, Inc.,Midas Pharma GmbH, Cycle Pharma, Dextra Laboratories Ltd., BASF SE,Chemcon Specialty Chemicals Pvt. Ltd, A.R. Life Sciences PrivateLimited, Dishman Group, Sanofi Winthrop Industrie S.A., ZCLChemicals Ltd., Vertellus Holdings LLC, Aceto Corporation,Lianhetech, and Easter Chemical Corporation.      

The global Pharmaceutical Intermediates Market is segmented asfollows:

By Application

  • Antibiotics
  • Vitamins
  • Antipyretic Analgesics

By Distribution Channel

  • Direct Sales
  • Distributor

By Product Type

  • GMP
  • Non-GMP

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

Free Analysis

FrequentlyAsked Questions

Rise in occurrence of chronic disorders such as diabetes, heart ailments, and kidney-related problems will drive market trends. As per WHO, persons above sixty years of age is projected to surpass 2 billion by 2050. Reportedly, WHO has also claimed diabetes to be major cause of heart attack, kidney failure, and stoke. In addition to this, prominently surging geriatric population will embellish growth of Pharmaceutical Intermediates Market over anticipated timeline. Apparently, use of new technologies including high throughput, combinatorial chemistry, and bio-informatics will prop up expansion of Pharmaceutical Intermediates industry over forecast timespan. Growing reach of various pharma players in emerging economies will pave way for expansion of Pharmaceutical Intermediates Market over assessment timeline.

Furthermore, wide use of Pharmaceutical Intermediates Market in domain of clinical research will prompt business expansion in upcoming years. In addition to this, outbreak of COVID-19 pandemic has encouraged players in biotech and pharmaceutical sectors to focus on drug production activities, thereby enlarging scope of Pharmaceutical Intermediates industry over assessment period.

According to Zion market research report, the global Pharmaceutical Intermediates Market accrued earnings worth approximately 28,117 (USD Million) in 2020 and is predicted to gain revenue of about 39,779 (USD Million) by 2028, is set to record a CAGR of nearly 4.1% over the period from 2021 to 2028.

North America will contribute lucratively towards the global market earnings over the projected timeline. The regional market surge is subject to surge in research & development activities in countries such as Canada and the U.S. Apart from this, surge in occurrence of myriad chronic conditions will further contribute towards regional market proceeds over upcoming years. For the record, heart disorder causes nearly 8 lac deaths in the U.S.

   

The key market participants include Codexis, Inc., Midas Pharma GmbH, Cycle Pharma, Dextra Laboratories Ltd., BASF SE, Chemcon Specialty Chemicals Pvt. Ltd, A.R. Life Sciences Private Limited, Dishman Group, Sanofi Winthrop Industrie S.A., ZCL Chemicals Ltd., Vertellus Holdings LLC, Aceto Corporation, Lianhetech, and Easter Chemical Corporation.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed